Description of rare mutations and a novel variant in Brazilian patients with Cystic Fibrosis: a case series from a referral center in the Bahia State

• Published in: Molecular biology reports Vol. 45; no. 6; pp. 2045 - 2051
• Main Authors: Mota, Laís Ribeiro, de Melo Filho, Valmir Machado, de Castro, Lorena Lemos, Garcia, Daniel Fantozzi, Terse-Ramos, Regina, Toralles, Maria Betânia Pereira, de Lima, Renata Lúcia Leite Ferreira, Souza, Edna Lúcia
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.12.2018; Springer Nature B.V
• Subjects: Animal Anatomy; Animal Biochemistry; Biomedical and Life Sciences; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Genotypes; Histology; Laboratories; Life Sciences; Medical records; Morphology; Mutation; Original Article; Pancreas; Phenotypes; Population genetics; Brazil; Genotype; Mucoviscidosis; Mutation; CFTR
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-018-4361-y

Knowledge of the genetic profile of Cystic Fibrosis (CF) contributes to a better understanding of the genotype/phenotype relationship, particularly in mixed populations such as in Brazil. To describe clinical data of CF patients with rare or not yet observed CFTR gene mutations in Brazil. It was a case series of CF patients followed-up at a referral center. Clinical and laboratory data were obtained through medical records. Molecular analysis of the mutations was performed by conventional methods and/or by next-generation sequencing. Ten patients were studied, seven had five pathogenic mutations without previous description in Brazil (Q1100P, Y109C, A107P, E1409K and K162E), one of which has not yet been reported in patients with CF (A107P). Among the seven patients, three (two siblings) had the second mutant allele of rare occurrence among Brazilians patients (G1069R and 2307insA). Three other patients also had at least one rare variant (V201M, S466X and G1069R). The age of the CF diagnosis ranged from 1 to 190 months in the ten cases and the main clinical manifestations were respiratory symptoms and difficulty in gaining weight. All but one patient presented clinical and/or laboratory data compatible with pancreatic insufficiency. The identification of rare or not yet described CFTR mutations in patients with CF in Brazil highlights the high genetic heterogeneity in this population. Knowledge of the genotypic profile of Brazilian CF patients can contribute to the development of specific mutation panels for the genetic investigation targeting each region of the country, as well as helping to understand the complex genotype/phenotype relationship, especially in mixed populations.